Harvard Women's Health Watch

Expert panel recommends new shingles vaccine

Research we’re watching A CDC advisory panel has recommended that some adults get vaccinated with a newly approved shingles vaccine. Officials hope the new vaccine, called Shingrix, will prove more effective than Zostavax, which until recently was the only shingles vaccine on the market. The Advisory Committee on Immunization Practices agreed on the recommendation at an October meeting, shortly after the FDA announced its approval of Shingrix for use in adults age 50…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In